Wickedness or folly? The ethics of NICE's decisions

Journal of Medical Ethics

Volumn 32, Issue 7, 2006, Pages 373-377

  Claxton, K ^a   Culyer, A J ^b  

^a UNIVERSITY OF YORK   (United Kingdom)

^b INSTITUTE FOR WORK AND HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGEISM; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EDITOR; HEALTH CARE ORGANIZATION; HUMAN RIGHTS; MEDICAL ETHICS; MEDICAL LITERATURE; MORALITY; NATIONAL HEALTH SERVICE; NOTE; PRACTICE GUIDELINE; QUALITY ADJUSTED LIFE YEAR; UNITED KINGDOM;

ACADEMIES AND INSTITUTES; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DRUG THERAPY; GREAT BRITAIN; HEALTH SERVICES ACCESSIBILITY; HUMANS; MORAL OBLIGATIONS; PREJUDICE; QUALITY OF HEALTH CARE; QUALITY-ADJUSTED LIFE YEARS; STATE MEDICINE;

EID: 33746086701     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.2006.016204     Document Type: Note

References (25)

1. National Institute for Health and Clinical Excellence. Appraisal consultation document: donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease, 2006. http://www.nice.org.uk/page.aspx?o=288826 (accessed 13 May 2006).
2. J Harris. It's not NICE to discriminate. J Med Ethics 2005;31:373.
3. J Broome. Trying to value a life. J Public Econ 1978;9:91-100.
4. GW Torrance. Measurement of health state utilities for economic appraisal. J Health Econ 1986;5:1-30.
5. CJ Murray, AK Acharya. Understanding DALYs. J Health Econ 1997;16:703-30.
6. A Mehrez, A Gafni. Quality-adjusted life-years, utility theory and healthy-years equivalents. Med Decis Making 1989;9:142-9.
7. WK Viscusi. The value of risks to life and health. J Econ Lit 1993;31:1912-46.
8. E Nord. Methods for quality adjustment of life years. Social Sci Med 1992;34:559-69.
9. E Nord. The person-trade-off approach to valuing health care programs. Med Decis Making 1995;15:201-8.
10. P Dolan, C Gudex, P Kind, et al. Valuing health states: a comparison of methods. J Health Econ 1996;15:209-31.
11. H Bleichrodt, M Johannesson. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs. J Health Econ 1997;16:155-75.
12. H Bleichrodt. A new explanation for the difference between time trade-off utilities and standard gamble utilities. Health Econ 2002;11:447-56.
13. E Nord, JL Pinto, J Richardson, et al. Incorporating societal concerns for fairness in numerical valuations of health programmes'. Health Econ 1999;8:25-39.
14. JA Olsen, C Donaldson. Helicopters, hearts and hips: using willingness to pay to set priorities for public sector health care programmes. Social Sci Med 1998;46:1-12.
15. A Diener, B O'Brien, A Gafni. Health care contingent valuation studies: a review and classification of the literature. Health Econ 1998;7:313-26.
16. AM Garber, CE Phelps. Economic foundations of cost effectiveness analysis. J Health Econ 1997;16:1-31.
17. D Meltzer. Accounting for future costs in medical cost-effectiveness analysis. J Health Econ 1997;16:33-64.
18. MC Weinstein, WG Manning Jr. Theoretical issues in cost-effectiveness analysis. J Health Econ 1997;16:121-8.
19. A Williams. Economics of coronary artery bypass grafting. Br Med J 1985;291:326-9.
20. A Williams. Outcome measurement in economic evaluation. Health Econ 1996;5:279-96.
21. J Richardson. Cost utility analysis: what should be measured. Social Sci Med 1994;39:7-21.
22. M Sculpher, E Fenwick, K Claxton. Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application. Pharmacoeconomics 2000;17:461-77.
23. Gold MR, Patrick DL, Torrance GW, et al. Identifying and valuing outcomes. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in health and medicine. Oxford: OUP, 1996:82-134.
24. DW Brock. Ethical issues in the use of cost-effectiveness analysis for the prioritization of health care resources. In: Edejer TT-T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, Murray CJL, eds. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization, 2003:289-312.
25. Williams A, Tsuchiya A, Dolan P. Eliciting equity-efficiency trade-offs in health. In: Smith PC, Ginnelly L, Sculpher M, eds. Health policy and economics: opportunities and challenges. Maidenhead: Open University Press, 2005:65-87.